Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

GBIO
Generation Bio Co. Common Stock
stock NASDAQ

At Close
Jul 18, 2025 3:59:46 PM EDT
0.4100USD-22.037%(-0.1149)4,595,611
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Jul 18, 2025 9:28:30 AM EDT
0.4361USD-16.360%(-0.0853)1,038,786
After-hours
Jul 18, 2025 4:58:30 PM EDT
0.4100USD+0.861%(0.0000)27,912
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 5, 2022
07:30AM EST  Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced today that the company will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 12, 2022.   GlobeNewswire Inc
Dec 19, 2021
09:37PM EST  Pomerantz LLP is investigating claims on behalf of investors of Generation Bio Co. (Generation or the Company) (NASDAQ: GBIO). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Dec 15, 2021
07:18AM EST  JMP Securities Maintains Market Outperform on Generation Bio, Lowers Price Target to $10   Benzinga
06:41AM EST  Needham Maintains Buy on Generation Bio, Lowers Price Target to $27   Benzinga
Dec 14, 2021
04:29PM EST  16:28 Tuesday, December 14, 2021Wedbush (RTTNews) - Wedbush Reiterates Generation Bio Co. (GBIO) At Outperform With $31 Down From $36 Price Target   RTTNews
02:39PM EST  Mid-Afternoon Market Update: Dow Falls 100 Points; Terminix Shares Spike Higher   Benzinga
12:40PM EST  Mid-Day Market Update: Nasdaq Tumbles 200 Points; MIND Technology Shares Jump   Benzinga
10:57AM EST  Hearing GBIO Downgraded to Market Perform at William Blair   Benzinga
10:13AM EST  Mid-Morning Market Update: Markets Mostly Lower; Producer Prices Rise 0.8% In November   Benzinga
10:12AM EST  Mid-Morning Market Update: Markets; Producer Prices Rise 0.8% In November   Benzinga
06:33AM EST  Generation Bio Provides Update On Preclinical Studies For Hemophilia A Program   Benzinga
06:30AM EST  Generation Bio Provides Update on Preclinical Studies for   GlobeNewswire Inc
Nov 10, 2021
06:43PM EST  Generation Bio Q3 EPS $(0.56) Down From $(0.46) YoY   Benzinga
Oct 22, 2021
07:33AM EDT  Generation Bio Highlights Presentation Of Data At European Society Of Gene And Cell Therapy 2021 Annual Virtual Congress   Benzinga
07:30AM EDT  Sub-retinal delivery of closed-ended DNA (ceDNA) using a retina-specific cell-targeted LNP (ctLNP) demonstrated broad photoreceptor distribution, durable expression and tolerability in rodents;potential to address inherited retinal diseases with full gene replacement   GlobeNewswire Inc
Oct 21, 2021
04:13PM EDT  Generation Bio To Present At Jefferies Virtual Gene Therapy/Editing Summit   Benzinga
04:05PM EDT  Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced today that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the Jefferies Virtual Gene Therapy/Editing Summit on Wednesday, October 27 at 5:00 p.m. ET.   GlobeNewswire Inc
Oct 15, 2021
07:30AM EDT  Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced an oral presentation at the European Society of Gene and Cell Therapy (ESGCT) Annual Virtual Congress taking place October 19-22. The presentation will highlight preclinical advances from the companys retina therapeutic area.   GlobeNewswire Inc
Aug 11, 2021
04:44PM EDT  Generation Bio Q2 EPS $(0.55) Up From $(1.50) YoY   Benzinga
04:20PM EDT  Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported recent business highlights and second quarter 2021 financial results.   GlobeNewswire Inc
Aug 3, 2021
07:30AM EDT  Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced today that Geoff McDonough, M.D., president and chief executive officer, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021 on Tuesday, August 10 at 9:10 a.m. ET.   GlobeNewswire Inc
Jul 14, 2021
07:32AM EDT  Generation Bio Outlines Plans To Deploy Next-Gen Rapid Enzymatic Synthesis For Manufacturing Of Its Closed-End DNA Constructs Across All Portfolio Programs   Benzinga
Jul 8, 2021
07:32AM EDT  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff McDonough, M.D., president and chief executive officer, will present at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, at 9:00 a.m. ET.   GlobeNewswire Inc
Jun 8, 2021
10:07AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2021   Benzinga
07:18AM EDT  JMP Securities Initiates Coverage On Generation Bio with Market Outperform Rating, Announces Price Target of $40   Benzinga
May 27, 2021
07:30AM EDT  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff McDonough, M.D., president and chief executive officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, at 11:30 a.m. ET.   GlobeNewswire Inc
May 12, 2021
04:43PM EDT  Generation Bio Q1 EPS $(0.46) Misses $(0.45) Estimate   Benzinga
04:20PM EDT  Durable, therapeutically relevant levels of anti-SARS-CoV-2 spike antibodies produced from the liver in a mouse model   GlobeNewswire Inc
Apr 27, 2021
05:02PM EDT  Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting   Benzinga
Apr 8, 2021
07:30AM EDT  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, at 3:00 p.m. ET.   GlobeNewswire Inc
Mar 18, 2021
08:07AM EDT  Generation Bio Q4 EPS $(0.53) Up From $(3.09) YoY   Benzinga
08:00AM EDT  $262.3 million cash balance at the end of 2020 bolstered by additional net proceeds of $211.3 million from follow-on offering, funding key milestones into 2024   GlobeNewswire Inc
Feb 24, 2021
10:07AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2021   Benzinga
06:05AM EST  William Blair Initiates Coverage On Generation Bio with Outperform Rating, Announces Price Target of $45   Benzinga
Feb 18, 2021
10:02AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021   Benzinga
07:30AM EST  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, announced today that Ron Cooper has been appointed to its Board of Directors. The appointment is effective March 1, 2021.   GlobeNewswire Inc
05:32AM EST  Needham Initiates Coverage On Generation Bio with Buy Rating, Announces Price Target of $50   Benzinga
Jan 16, 2021
02:22PM EST  Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity   Benzinga
Jan 11, 2021
05:43PM EST  Generation Bio Announces Closing of Public Offering   GlobeNewswire Inc
Jan 6, 2021
10:37PM EST  Generation Bio Prices Public Offering Of 8 Mln At $24.50/shr   RTTNews
09:24PM EST  Generation Bio Announces Pricing of Public Offering   GlobeNewswire Inc
Jan 5, 2021
02:33PM EST  Mid-Afternoon Market Update: Dow Climbs 250 Points; Boston Private Shares Spike Higher   Benzinga
12:21PM EST  Mid-Day Market Update: Crude Oil Surges Over 4%; Generation Bio Shares Slide   Benzinga
08:39AM EST  The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data   Benzinga
06:30AM EST  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that the company will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021.   GlobeNewswire Inc
Jan 4, 2021
04:07PM EST  Generation Bio Announces 7.5M Share Common Stock Offering   Benzinga
06:31AM EST  Generation Bio Announces Two Non-Viral Gene Therapy Milestone Achievements: Target Levels of Factor VIII Expression in Hemophilia A Mice and Translation of Expression from Mice to Non-Human Primates   Benzinga
06:30AM EST  Data confirm delivery of closed-ended DNA to the liver via novel, cell-targeted lipid nanoparticles   GlobeNewswire Inc
Dec 8, 2020
10:59PM EST  The lockup period of Generation Bio Co. (GBIO) ends on December 9, 2020.   RTTNews
Dec 4, 2020
08:04AM EST  The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs   Benzinga
Dec 2, 2020
07:35AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod   Benzinga
Dec 1, 2020
08:08AM EST  The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit   Benzinga
Nov 25, 2020
07:35AM EST  The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback   Benzinga
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
Nov 18, 2020
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 17, 2020
08:32AM EST  The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration   Benzinga
Nov 13, 2020
07:40AM EST  The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations   Benzinga
Nov 10, 2020
06:30AM EST  Generation Bio Co. (Nasdaq: GBIO) is an innovative genetic medicines company creating a new class of non-viral gene therapy. Today the company reported recent business highlights and third quarter financial results.   GlobeNewswire Inc
Oct 5, 2020
06:30AM EDT  Generation Bio to Present at 2020 Virtual Cell & Gene Meeting on   GlobeNewswire Inc
Sep 24, 2020
06:30AM EDT  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff McDonough, M.D., president and chief executive officer, will present at the Jefferies 2020 Virtual Gene Therapy/Editing Summit on Thursday, Oct. 1 at 11:00 a.m. ET.   GlobeNewswire Inc
Aug 11, 2020
06:41AM EDT  Generation Bio Q2 EPS $(1.50) Up From $(3.30) YoY   Benzinga
06:30AM EDT  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today reported recent business highlights and second quarter financial results.   GlobeNewswire Inc
Aug 5, 2020
06:30AM EDT  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced that management will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, Aug. 12, 2020 at 10:20 a.m. ET.   GlobeNewswire Inc
Jul 22, 2020
07:23AM EDT  Generation Bio Appoints Matthew Norkunas As CFO   RTTNews
07:09AM EDT  Generation Bio Appoints Matthew Norkunas, M.D., MBA As Chief Financial Officer   Benzinga
07:00AM EDT  Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced that Matthew Norkunas, M.D., MBA, has been appointed chief financial officer.   GlobeNewswire Inc
Jul 20, 2020
05:11AM EDT  80 Biggest Movers From Friday   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC